Michael Schurr, PhD

Publications

• Kleymann AM, Zawadzki NA, Fong DL, Fink MK, Habenicht LM, Leszczynski JK, Anderson SM, Schurr MJ, Manuel CA. Corynebacterium bovis Growth in Tissue Culture Conditions and Media. J Am Assoc Lab Anim Sci. 2024 Aug 24. [Epub ahead of print] PubMed PMID: 39181706
• Manuel CA, Pugazhenthi U, Fink MK, Habenicht LM, Fong DL, Leszczynski JK, Schurr MJ. A Clinical Scoring System and Impact of Athymic Nude Mouse Age on Corynebacterium bovis Clinical Disease. Comp Med. 2024 Aug 1;74(4):246-254. PubMed PMID: 38704217
• Jenul C, Keim KC, Jens JN, Zeiler MJ, Schilcher K, Schurr MJ, Melander C, Phelan VV, Horswill AR. Pyochelin biotransformation by Staphylococcus aureus shapes bacterial competition with Pseudomonas aeruginosa in polymicrobial infections. Cell Rep. 2023 Jun 27;42(6):112540. PubMed PMID: 37227819
• Pires EM, Pugazhenthi U, Fink MK, Habenicht LM, Fong DL, Leszczynski JK, Schurr MJ, Manuel CA. Antibiotic Treatment of Corynebacterium bovis-associated Clinical Disease in NSG Mice. Comp Med. 2023 Dec 1;73(6):461-465. PubMed PMID: 38103891
• Taylor JZ, Fong DL, Habenicht LM, Fink MK, Leszczynski JK, Frank DN, Kofonow JM, Robertson CE, Nicklawsky AG, Schurr MJ, Manuel CA. Effects of Extended Cage Component Sanitation Interval on the Microenvironment, Health, and Gastrointestinal Microbiome of Rats (Rattus norvegicus). J Am Assoc Lab Anim Sci. 2023 May 1;62(3):212-221. PubMed PMID: 37072181
• Trivedi R, Gautam D, Kehe GM, Escobedo HD, Patel K, Stansbury JW, Schurr MJ, Nair DP. Synthesis, characterization and evaluation of azobenzene nanogels for their antibacterial properties in adhesive dentistry. Eur J Oral Sci. 2022 Feb;130(1):e12832. doi: 10.1111/eos.12832. Epub 2021 Dec 19.PMID: 34923692.
• Manuel CA, Johnson LK, Pugazhenthi U, Fong DL, Fink M, Habenicht LM, Leszczynski JK, Diana IR, Schurr MJ, Frank DN. Effect of Antimicrobial Prophylaxis on Corynebacterium bovis Infection and the Skin Microbiome of Immunodeficient Mice. Comp Med. 2022 Apr 1;72(2):78-89. doi: 10.30802/AALAS-CM-21-000082. Epub 2022 Apr 4.PMID: 35379380
• Fagre, A.C., Pugazhenthi, U., Cheleuitte-Nieves, C., Crim, M.J., Henderson, K.S., Fong, D.L., Leszczynski, J.K., Schurr, M.J., Daniels, J.B., Manuel, C. A. 2021. Antimicrobial Susceptibility of Corynebacterium bovis Isolates from Immunodeficient Rodents. Comparative Medicine. 71:1-5. DOI: 10.30802/AALAS-CM-20-000107.
• Misischia WP, Xenoudi P, Yukna RA, Schurr MJ. Correction to: Bacterial reduction effect of four different dental lasers on titanium surfaces in vitro. Lasers Med Sci. 2021 Oct;36(8):1769. PubMed PMID: 34427850
• Misischia WP, Xenoudi P, Yukna RA, Schurr MJ. Bacterial reduction effect of four different dental lasers on titanium surfaces in vitro. Lasers Med Sci. 2021 Oct;36(8):1759-1767. PubMed PMID: 34313893
• Hassett DJ, Kovall RA, Schurr MJ, Kotagiri N, Kumari H, Satish L. The Bactericidal Tandem Drug, AB569: How to Eradicate Antibiotic-Resistant Biofilm Pseudomonas aeruginosa in Multiple Disease Settings Including Cystic Fibrosis, Burns/Wounds and Urinary Tract Infections. Front Microbiol. 2021;12:639362. PubMed PMID: 34220733
• Bogue, A.L., Panmanee, W., McDaniel1, C.T., Mortensen, J.E., Kamau, E., Actis, L.A., Johannigman, J.A., Schurr,M.J., Kotagiri L.S.N., Hassett, D.J.. 2021. AB569, a non-toxic combination of acidified nitrite and EDTA, is effective at killing the notorious Iraq/Afghanistan combat wound pathogens, multi-drug resistant Acinetobacter baumannii and Acinetobacter spp. PLoS ONE 16(3): e0247513. doi.org/10.1371/journal.pone.0247513
• Mori, D. I.; Schurr, M. J.; Nair, D. P. “Selective Inhibition of Streptococci Biofilm Growth via a Hydroxylated Azobenzene Coating,” Advanced Materials Interfaces, 2020, 1902149.
• McDaniel CT, Panmanee W, Winsor GL, Gill E, Bertelli C, Schurr MJ, Dongare P, Paul AT, Ko SB, Lau GW, Dasgupta N, Bogue AL, Miller WE, Mortensen JE, Haslam DB, Dexheimer P, Muruve DA, Aronow BJ, Forbes MDE, Danilczuk M, Brinkman FSL, Hancock REW, Meyer TJ, Hassett DJ. AB569, a nontoxic chemical tandem that kills major human pathogenic bacteria. Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4921-4930. PubMed PMID: 32071223
• Schurr MJ. Pseudomonas aeruginosa Alginate Benefits Staphylococcus aureus?. J Bacteriol. 2020 Mar 26;202(8). PubMed PMID: 32015142
• Pearson EC, Pugazhenthi U, Fong DL, Smith DE, Nicklawsky AG, Habenicht LM, Fink MK, Leszczynski JK, Schurr MJ, Manuel CA. Metaphylactic Antibiotic Treatment to Prevent the Transmission of Corynebacterium bovis to Immunocompromised Mouse Offspring. J Am Assoc Lab Anim Sci. 2020 Nov 1;59(6):712-718. PubMed PMID: 32907697
• Mitchell CM, McGrath A, Beck B, Schurr MJ, Fong D, Leszczynski JK, Manuel CA. Low-cost, Small-scale Decontamination of Laboratory Equipment by Using Chlorine Dioxide Gas. J Am Assoc Lab Anim Sci. 2019 Sep 1;58(5):569-576. PubMed PMID: 31466553
• Panmanee W, Su S, Schurr MJ, Lau GW, Zhu X, Ren Z, McDaniel CT, Lu LJ, Ohman DE, Muruve DA, Panos RJ, Yu HD, Thompson TB, Tseng BS, Hassett DJ. The anti-sigma factor MucA of Pseudomonas aeruginosa: Dramatic differences of a mucA22 vs. a ?mucA mutant in anaerobic acidified nitrite sensitivity of planktonic and biofilm bacteria in vitro and during chronic murine lung infection. PLoS One. 2019;14(6):e0216401. PubMed PMID: 31158231
• Kehe GM, Mori DI, Schurr MJ, Nair DP. Optically Responsive, Smart Anti-Bacterial Coatings via the Photofluidization of Azobenzenes. ACS Appl Mater Interfaces. 2019 Jan 16;11(2):1760-1765. PubMed PMID: 30605328
• Yuta Okkotsu, Christopher L. Pritchett and Michael J. Schurr. Regulation of Exopolysaccharide biosynthesis in Pseudomonas aeruginosa. M.L. Vasil and A. Darwin. Regulation of Bacterial Virulence. Washington D.C. 2013.
• Schurr MJ. 2013. Which Bacterial Biofilm Exopolysaccharide is Preferred, Psl or Alginate? J Bacteriol. Feb 15. [Epub ahead of print]
• Petrova OE, Schurr JR, Schurr MJ, Sauer K. 2012. Microcolony formation by the opportunistic pathogen Pseudomonas aeruginosa requires pyruvate and pyruvate fermentation. Mol Microbiol. 86: 819-835.
• Yuta Okkotsu, Christopher L. Pritchett and Michael J. Schurr. Regulation of Exopolysaccharide biosynthesis in Pseudomonas aeruginosa. M.L. Vasil and A. Darwin. Regulation of Bacterial Virulence. Washington D.C. 2012.
• Crabbe, A., Schurr, M. J., Monsieurs, P., Morici, L., Schurr, J., Wilson, J. W., Ott, C. M., Tsaprailis, G., Pierson, D., Stefanyshyn-Piper, H., and Nickerson, C. A. 2011. Transcriptional and proteomic response of Pseudomonas aeruginosa PAO1 to spaceflight conditions involves Hfq regulation and reveals a role for oxygen. Appl. & Environ. Microbiol. 77:1221-1230.
• Kuang, Z., Hao, Y., Hwang, S., Zhang, S., Kim, E., Akinbi, H. T., Schurr, M. J., Irvin, R. T., Hassett, D. J., Lau, G.W. 2011. The Pseudomonas aeruginosa flagellum confers resistance to pulmonary surfactant protein-A by impacting the production of exoproteases through quorum-sensing. Mol. Microbiol. 79:122-1235.
• Cross, R.W., Betancourt, A.M., Schurr, M.J., Norton, E.B., Roy, D., Hartley, T., and Voss, T.G. 2011. Impact of Primary Influenza infection on the immune response to secondary bacterial infection in aged mice. Influenza and other Resp. Viruses. 5:195-201.
• Petrova, O. E., Schurr, J. R., Schurr, M. J., and K. Sauer. 2011. The novel Pseudomonas aeruginosa two-component regulator BfmR controls bacteriophage mediated lysis and DNA release during biofilm development through PhdA. Mol. Microbiol. 81:767-83.
• Damron FH, Owings JP, Okkotsu Y, Varga JJ, Schurr JR, Goldberg JB, Schurr MJ, Yu HD. 2011. Analysis of the Pseudomonas aeruginosa regulon controlled by the sensor kinase KinB and sigma factor RpoN. J. Bacteriol. 2011 194:1317-30.
• Jones A. K., Fulcher N. B., Balzer G. J., Urbanowski M. L., Pritchett C. L., Schurr M. J., Yahr T. L., M. C. Wolfgang. 2010. Activation of the Pseudomonas aeruginosa AlgU regulon through mucA mutation inhibits cyclic AMP/Vfr signaling. J Bacteriol. 192:5709-17.
• Hassett, D. J., Korfhagen, T. R., Irvin, R. T., Schurr, M. J., Sauer, K, Lau, G. W., Sutton, M. D., Yu, H. and Hoiby, N. 2010. Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies. Expert Opin. Ther. Targets.14(2):117-30.
• Kuang, Z., Hao, Y., Hwang, S., Zhang, S., Kim, E., Akinbi, H. T., Schurr, M. J., Irvin, R. T., Hassett, D. J., Lau, G.W. 2011. The Pseudomonas aeruginosa flagellum confers resistance to pulmonary surfactant protein-A by impacting the production of exoproteases through quorum-sensing. Mol. Microbiol. 79:122-1235.
• Cross, R.W., Betancourt, A.M., Schurr, M.J., Norton, E.B., Roy, D., Hartley, T., and Voss, T.G. 2011. Impact of Primary Influenza infection on the immune response to secondary bacterial infection in aged mice. Influenza and other Resp. Viruses. In press.
• Pritchett, C. L.,Vitko, N. P., and Schurr, M. J. Autoregulation and Expression of the Pseudomonas aeruginosa AlgZR two-component regulatory system. Submitted J. Bacteriol.
• Okkotsu, Y., and M. J. Schurr. Phosphorylated Pseudomonas aeruginosa AlgR represses rhamnolipid and pyocyanin production. New Orleans, LA. 2011
• Crabbe, A., Schurr, M. J., Monsieurs, P., Morici, L., Schurr, J., Wilson, J. W., Ott, C. M., Tsaprailis, G., Pierson, D., Stefanyshyn-Piper, H., and Nickerson, C. A. 2010. Transcriptional and proteomic response of Pseudomonas aeruginosa PAO1 to spaceflight conditions involves Hfq regulation and reveals a role for oxygen. Applied and Environ. Microbiol. Appl. & Environ. Microbiol. 77:1221-1230.
• Pritchett, C.L. and M. J. Schurr. RpoS involvement in controlling the algZR operon. B-104. ASM Annual Meeting, San Diego, CA, 2010.
• Mori, D.I., Powell, A., Kehe, G.M., Schurr, M.J., Nair, D.P., Puranik, C.P.. 2021. Acrylated hydroxyazobenzene copolymers in composite-resin matrix inhibits S. mutans biofilms in vitro. Pediatric Dentistry.